Pregnancy SmartShop formulas

Is it safe? · Pregnancy Smart

PGT-M Testing: Planning for an Inherited Condition

Assigned clinical reviewerMichael Yuzefovich· MD, FACOGDraft · pending clinical reviewUpdated

What does the evidence say about pgt-m testing?

  1. PGT-M often requires confirmation of the family's genetic variant and a customized laboratory test. Relatives' samples may be requested, and development can take time. Confirm laboratory acceptance and readiness before assuming an IVF start date is workable. 1
  2. PGT-M answers a different question from PGT-A, which screens chromosome number. A result for one specified condition does not establish that an embryo has no other genetic findings or future health risks. 2
  3. A genetics consultation can explain the inheritance pattern, available testing, and what a result would mean for family planning. Bring original laboratory reports when possible, because a condition name alone may not identify the variant needed for the embryo test. 3
  4. Adding PGT-A to PGT-M introduces a separate screening decision. ASRM has not established that routine PGT-A benefits every IVF patient. Ask what additional information is expected and how the combination could affect the embryos available for transfer. 4
  5. Chorionic villus sampling is one prenatal diagnostic option that may be discussed after PGT-M. ASRM also describes amniocentesis as a confirmatory option. The genetics and prenatal teams can explain the timing, information, and procedure risks relevant to your pregnancy. 5

How does PGT-M planning fit around an IVF cycle?

  • Before IVF, clarify the family variant, laboratory acceptance, and preparation timeline.
  • Before transfer, review the meaning and limitations of each embryo result.
  • During pregnancy, discuss confirmation with the prenatal and genetics teams.

Questions for your fertility or prenatal team

Decision pointWhat to clarify
Test preparationIs the family variant confirmed, and are additional samples needed?
Possible resultsHow will affected, carrier, inconclusive, or other findings be reported?
Pregnancy follow-upWhich prenatal test could confirm the condition-specific result?

Frequently asked questions

Who may consider PGT-M?

People with an identified reproductive risk involving a known single-gene condition may discuss it with a genetics and fertility team. Laboratory feasibility and the exact inheritance pattern matter; a family history alone does not settle eligibility.

Why does the laboratory need my original genetic report?

The test may need to target a particular variant rather than a broad condition label. The laboratory reviews the reported finding and family information when deciding whether and how it can build an informative embryo test.

Could relatives need to provide samples?

Yes, depending on the test design. Ask which relatives might be involved and why, before starting IVF. The need for family participation can affect timing, privacy preferences, and whether the planned analysis is feasible.

Is PGT-M the same as PGT-A?

No. PGT-M addresses a specified single-gene condition. PGT-A screens chromosome number. Clinics sometimes offer both, so request separate explanations of each test's purpose, limitations, and effect on transfer decisions.

Does PGT-M guarantee an embryo suitable for transfer?

No. IVF may produce few embryos, and genetic findings or inconclusive results can further limit transfer options. Discuss that possibility before the cycle, including what the clinic would recommend if no embryo meets your agreed criteria.

Is PGT-M required if I carry a genetic condition?

ASRM describes it as optional. Counseling should support your choices and explain alternatives, including prenatal testing or other family-building pathways. The decision depends on your circumstances, values, and the reproductive risk involved.

Should I still discuss prenatal confirmation after PGT-M?

Yes. Technical limitations can lead to an incorrect embryo result. ASRM recommends discussing prenatal diagnostic testing, including chorionic villus sampling or amniocentesis, to confirm the relevant finding during pregnancy.

What if a test result is inconclusive?

Ask the laboratory and genetic counselor what caused the uncertainty, whether more information could help, and how the result affects transfer options. Do not interpret an inconclusive report as either a reassuring negative or a confirmed finding.

References

  1. Indications and management of preimplantation genetic testing for monogenic conditions: a committee opinion

    ASRM · https://www.asrm.org/practice-guidance/practice-committee-documents/indications-and-management-of-preimplantation-genetic-testing-for-monogenic-conditions-a-committee-opinion-2023/

  2. Preimplantation Genetic Testing

    ACOG · https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2020/03/preimplantation-genetic-testing

  3. What happens during a genetic consultation?

    MedlinePlus · https://medlineplus.gov/genetics/understanding/consult/expectations/

  4. The use of preimplantation genetic testing for aneuploidy: a committee opinion

    ASRM · https://www.asrm.org/practice-guidance/practice-committee-documents/the-use-of-preimplantation-genetic-testing-for-aneuploidy-a-committee-opinion-2024/

  5. Chorionic Villus Sampling (CVS)

    MedlinePlus · https://medlineplus.gov/lab-tests/chorionic-villus-sampling-cvs/

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.